Delian Capital

Delian Capital, established in 2011 and based in Beijing, China, is an early and growth stage venture capital firm that focuses on tech-driven industries. The firm invests in advanced manufacturing, cutting-edge technologies, and healthcare, with a portfolio that includes companies in robotics, smart manufacturing, semiconductors, artificial intelligence, big data, and enterprise services. Notable investments include YueBoo, Hunan Zhongli, Esafenet, Venus MedTech, MicuRx, Rokae, IMI, and 12 Sigma Technologies. In addition to venture capital, Delian Capital also explores private equity opportunities within these sectors.

Fang Hong

Managing Director

78 past transactions

Core Medical Technology

Series D in 2025
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

VelaVigo

Seed Round in 2024
VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.

X Square

Seed Round in 2024
X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.

Juntong Future

Seed Round in 2024
Juntong Future is an artificial intelligence and digital intelligence security service provider that focuses on the governance and compliance challenges of artificial intelligence itself

PulseCare

Series A in 2024
PulseCare is a medtech company that specializes in innovative medical devices and solutions for cardiac and pan-vascular treatment.

Reju Therapeutics

Seed Round in 2024
Reju Therapeutics, a biopharmaceutical company, is dedicated to research and development of drugs for treating degenerative diseases like neurodegenerative, fibrotic, and inflammatory conditions.

Yitai Microelectronics

Seed Round in 2024
Yitai Microelectronics is an automotive Ethernet chip developer company that specializes on producing high-performance, high-reliability, and low-power automotive Ethernet communication chips and systems.

Rokae

Venture Round in 2024
Rokae specializes in the research, development, production, and application of lightweight industrial robots and advanced robot control systems aimed at enhancing industrial automation. The company focuses on delivering high-performance robotic products and interactive control systems across various sectors, including computing, communications, consumer electronics, textiles, food, medicine, and automotive manufacturing. By emphasizing independent research and development, Rokae aims to provide tailored hardware and integrated application solutions that add significant value for high-end manufacturers.

Akaso Bio

Seed Round in 2024
Akaso Bio is a leader in 3D microfluidic chip technology, dedicated to exploring and expanding new applications of high-throughput microfluidic technology, and becoming an innovative solution provider for high-performance microsphere products.

Daoyi Semiconductor

Seed Round in 2024
Daoyi Semiconductor is a company that specializes in the research and development, manufacturing, sales, and technical support of epoxy plastic encapsulating materials for various semiconductor devices, integrated circuits, power modules, and other electronic packaging.

Pai Rui Semiconductor

Seed Round in 2023
Pai Rui Semiconductor is an integrated circuit design specialist with a focus on high-performance mixed-signal technology. Its main objective is to aid in the quantification of analog signals by use of sub-gate and ultra-high-precision differential delay chains that are independently created.

Jingfei Semiconductor

Angel Round in 2023
Jingfei Semiconductor manufactures semiconductor laser processing equipment. It is primarily concerned with the design, development, and manufacture of laser-related equipment and processes in the semiconductor industry.

iCamumo

Series A in 2023
Aikai Biotech is focused on developing a new generation of off-the-shelf general-purpose cell therapy pharmaceuticals using iPSC.

Tree Industrial Manufacturing

Series A in 2023
Hunan Tree Industrial Manufacturing focuses on the production of automatic robots and equipment tailored for casting, sanding, and polishing processes. The company specializes in manufacturing robotic grinding machines designed specifically for high-tech factories. Their products are compatible with various factory environments, allowing users to implement advanced grinding solutions across different manufacturing settings. By emphasizing automation and efficiency, Hunan Tree Industrial Manufacturing aims to enhance productivity in the industrial sector.

Yaoshi Medical

Series A in 2023
Yaoshi Medical conducts research and development in the field of ocular illness diagnosis and screening equipment.

Dify.AI

Seed Round in 2023
Dify is an open-source LLM app development platform. Dify's intuitive interface combines AI workflow, RAG pipeline, agent capabilities, model management, observability features and more, letting you quickly go from prototype to production.

D2M Biotherapeutics

Series A in 2023
D2M Biotherapeutics focuses on the development of novel immunotherapeutics. The company is a tumor immunological drug developer that aims to expand the potential of immunotherapy.

Qinglian Biotech

Series A in 2023
Qinglian Biotech is an innovative proteomics detection technology service provider.

D2M Biotherapeutics

Series A in 2022
D2M Biotherapeutics focuses on the development of novel immunotherapeutics. The company is a tumor immunological drug developer that aims to expand the potential of immunotherapy.

Macrotest

Venture Round in 2022
Macrotest is a company focused on the research, development, testing, and marketing of semiconductor equipment. It specializes in creating integrated circuit testing equipment, including high-speed digital, high-voltage high-current analog, mixed-signal, and RF integrated circuits. Additionally, Macrotest develops automated test equipment (ATE) and various test boards, offering comprehensive back-end solutions for the semiconductor industry. The company holds multiple domestic patents and trademarks for its software and hardware innovations, reinforcing its commitment to advancing technology in the semiconductor sector.

Juexin Technology

Seed Round in 2022
Juexin Technology is an entity that designs high-speed optoelectronic chips. Its primary focus is on the development of electrical chips for high-speed optical communications.

Redbud Medicine

Series A in 2022
Redbud Medicine specializes in providing clinical trial services tailored for the pharmaceutical and biotechnology sectors. The company is dedicated to optimizing and accelerating clinical development processes, which helps clients reduce operational costs and expedite studies. By focusing on real-time data analysis during innovation and trials, Redbud Medicine supports both local Chinese biotechnology firms in navigating the global market and foreign biotechnology companies seeking to introduce their products in China. Through its innovative and efficient services, Redbud Medicine facilitates the advancement of biotechnological innovations on an international scale.

Trinova Technology

Series B in 2022
Trinova specializes in the development and production of advanced automotive electronic systems, focusing on intelligent wire-controlled chassis and safety technologies. The company is engaged in creating a range of innovative products, including redundant electronically controlled steering, eBooster, and various advanced safety systems such as electronic stability control and autonomous driving components. Trinova's expertise encompasses the entire process from research and development to testing, manufacturing, and calibration of automotive chassis electronic control products. By prioritizing high-quality standards, Trinova aims to enhance vehicle dynamics control and contribute to the advancement of smart driving safety technologies in the automotive industry.

Mech-Mind Robotics

Series C in 2022
Mech-Mind Robotics Technologies, founded in 2016 and based in Beijing, China, specializes in manufacturing smart cameras and developing AI-powered software for the logistics industry. The company produces a range of cameras, including the Mech-Eye Smart Camera, designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind's technology integrates 3D vision with artificial intelligence, enabling robots to recognize objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in addressing complex automation challenges, including logistics parcel picking and related operations. The company also maintains an office in Munich, Germany, and a sales office in Shanghai, China.

Zhongqu Technology

Series B in 2022
Zhongqu (Beijing) Technology Co., Ltd. is a company that specializes in the development of 3D scanning camera technology. Founded in 2014, it is located in Beijing, China. The company focuses on creating innovative solutions in the field of 3D scanning, catering to various applications and industries.

AIForceTech

Series A in 2022
AIForceTech is a company focused on agricultural robotics and smart machinery, based in Beijing's Haidian District since its founding in 2019. The company develops and manufactures a range of electric-powered agricultural products, including unmanned electric tractors and various robotic solutions. Leveraging artificial intelligence and autonomous driving technology, AIForceTech's equipment is designed to operate unmanned around the clock, significantly enhancing agricultural efficiency. The practical application of its products in real-world scenarios has provided the company with valuable operational insights, driving innovation in the agricultural sector.

Immunofoco

Seed Round in 2022
Immunofoco is a biotechnology company focused on developing innovative immune cell therapies for patients with solid tumors. The company aims to transform solid tumors into hematological malignancies, utilizing a unique clinical strategy that addresses the challenges associated with traditional solid tumor treatments. By introducing advanced CAR-T (chimeric antigen receptor) therapies to the Chinese market, Immunofoco seeks to improve treatment outcomes and enhance long-term survival rates for patients. Their approach leverages the clinical benefits observed in treating hematologic malignancies, offering a new perspective on tumor therapy and contributing to the advancement of cancer treatment options.

Hesguard

Seed Round in 2021
Hesguard is a medical device developer and producer of high-end implantable medical devices related to ophthalmic diseases.

Yuneng Technology

Series A in 2021
Yuneng Technology specializes in the research and development of advanced soft magnetic materials, primarily aimed at enhancing battery performance and wireless charging efficiency. The company focuses on nanocrystalline material formulations and innovative magnetic isolation sheet processes. These technologies enable improved charging power and efficiency, catering to clients across various sectors, including consumer electronics, new energy vehicles, and the photovoltaic industry. By providing powerful and efficient magnetic materials, Yuneng Technology supports the advancement of electronics and energy solutions.

Yuntian Semiconductor

Series B in 2021
Yuntian Semiconductor is a semiconductor firm that develops TGV technology, filter wafer-level 3-D packaging technology, and IPD technology.

Lips Semiconductor

Series A in 2021
Lipps is a research and development, production and sales company of power semiconductor components. It can independently design IGBT/SIC, MOSFET modules and IPM module products, and has established a cooperative relationship with Japanese power module packaging factories.

Danwang Medical

Series A in 2021
Danwang Medical provides clinical transformation technology services to regenerative medicine for disease diagnosis and treatments. They also provide organoid drug sensitivity testing, organoid disease models, organoid drug development, and organoid chips. Danwang Medical is committed to applying the most recent clinical transformation technology of regenerative medicine to disease diagnosis and treatment, new drug screening, tumor marker development and identification, and other areas in order to provide clinical personalized treatment technology and accurate, efficient, and high-quality organoids Model to new drug research and development enterprises.

CalmCar Vision System

Series C in 2021
CalmCar Vehicle Vision is a Chinese intelligent driving vision system provider. They are specialized in developing intelligent vision system for ADAS, autopilot and autonomous driving with functions of Lane Departure Warning (LDW), Front Collision Warning (FCW), Pedestrian Collision Warning(PCW), Blind Spot Detection (BSD) and Traffic Sign Recognition (TSR).

xMEMS

Series A in 2021
xMEMS, founded in 2018 and headquartered in Santa Clara, California, specializes in developing innovative audio solutions for consumer electronics. The company focuses on creating advanced speakers designed for in-ear personal audio devices, addressing the need for improved audio fidelity and extended battery life. By utilizing a high-precision, monolithic semiconductor process, xMEMS offers a superior alternative to traditional voice coil and hybrid micro-electromechanical system technologies. This approach allows for greater consistency and uniformity in sound quality, enabling customers to replace outdated, manually-assembled speaker technologies with modern, efficient solutions.

Juventas

Series C in 2021
Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.

AIForceTech

Series A in 2021
AIForceTech is a company focused on agricultural robotics and smart machinery, based in Beijing's Haidian District since its founding in 2019. The company develops and manufactures a range of electric-powered agricultural products, including unmanned electric tractors and various robotic solutions. Leveraging artificial intelligence and autonomous driving technology, AIForceTech's equipment is designed to operate unmanned around the clock, significantly enhancing agricultural efficiency. The practical application of its products in real-world scenarios has provided the company with valuable operational insights, driving innovation in the agricultural sector.

Hong Jing Drive

Series A in 2021
Hong Jing Drive is a comprehensive provider of autonomous driving solutions, established on May 2, 2018, by Feilong Liu in Hangzhou, Zhejiang. The company specializes in developing a full-stack software system that integrates both software and hardware design, focusing on the computing needs of autonomous vehicles. Hong Jing Drive offers services that include the selection and layout of sensors, as well as calibration for autonomous driving systems. Its mission is to deliver safe and efficient transportation methods through innovative technology.

ETHA

Seed Round in 2021
ETHA Labs is a community-driven incubator focused on fostering DeFi projects to promote mass adoption by reducing entry barriers for both institutional and retail users. The ecosystem consists of two main segments: ETHA Lab (Build), which develops essential infrastructure and tools for DeFi, and ETHA Lab (Incubate), which encourages innovation in external DAO-based DeFi initiatives. Additionally, ETHA operates as a protocol-agnostic yield optimizer, utilizing Ethereum and Polkadot technologies to streamline access to optimal yields across various platforms. A key component of the platform, ETHA Lend, aims to maximize returns from DeFi liquidity pools while supporting a wide array of digital assets. Overall, ETHA seeks to simplify the complexities associated with DeFi investments, and its ecosystem is powered by the ETHA token, which plays a crucial role in governance and operational functions.

Zhishan Weixin Biotechnology

Series A in 2021
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.

Tapdata

Seed Round in 2021
TapData is a software company that specializes in real-time data integration and management solutions. It offers a Data as a Service (DaaS) platform designed to support enterprises in China, focusing on online transaction processing (OLTP) sectors. By utilizing technologies such as MongoDB and Elastic Search, TapData aims to eliminate data silos and create a comprehensive enterprise data layer. This enables organizations to access and analyze their data effectively, fostering innovation and streamlining operations. The company's services facilitate the rapid establishment of real-time data centers and enhance capabilities for data processing and synchronization across databases.

Polaris Biology

Series B in 2020
Polaris Biology is a medical technology company focused on the development and clinical application of cell-level precision diagnostic technology. The company aims to enhance tumor diagnosis and treatment by studying individual and dynamic changes in tumors at the cellular level. Utilizing artificial intelligence algorithms and drug-system biological models, Polaris Biology provides advanced diagnostic tools designed to offer direct and accurate clinical support for cancer treatment. These innovations are intended to empower both patients and physicians in making informed decisions regarding cancer care.

Sophonix

Series B in 2020
Sophonix Co., Ltd. is a company dedicated to the manufacturing of in vitro diagnostic equipment and reagents. Founded in 2017 and headquartered in Beijing, China, with an additional office in California, the firm specializes in the development and production of diagnostic instruments that facilitate accurate point-of-care testing (POCT) solutions. Its product offerings include automatic chemiluminescence immune analyzers, automatic immunohistochemical staining apparatus, and various chemiluminescence immunoassay reagents. Sophonix aims to provide highly sensitive and accurate testing results to assist healthcare professionals in making precise diagnoses.

YEESTOR

Series B in 2020
YEESTOR Microelectronics focuses on the developing and sales of storage controllers and manufactures of NAND Flash memory control chips. YEESTOR has been dedicated to continuous technical innovation, professional technical support and one-stop service for customers to achieve faster design cycles, higher resource utilization efficiency, and a more reliable storage system. YEESTOR closely follows the frontier of the market, compactly cooperates with module manufacturers and system manufacturers with overall arrangement, providing customers with complete turnkey solution and customized development platform. YEESTOR has mastered numerous key technologies in the industry, has various core invention patents at home and abroad, and has extensive global market operations experience. YEESTOR’s main product are storage controllers, including PCIe SSD Controller, SATA SSD Controller, UFS Controller, eMMC Controller, USB Controller, SD Controller and Security Storage Controller. Products are widely applied in data centers, servers, PCs, smart phones, tablet computers, smart homes, Internet of things, etc. YEESTOR was established in 2017 with headquarter in Shenzhen, branching in Hong Kong, Taiwan Hsinchu, Shanghai, Hefei and other places. YEESTOR was formed by the merger of SiliconGo (founded in 2007) and Auspitek (founded in 2015). YEESTOR is a significant global supplier of flash memory controller. Up to 2017, the cumulative shipments of YEESTOR and its predecessors reached 700 million units, which makes for a leader position in the industry.

Fit2Cloud

Series C in 2020
FIT2CLOUD, established in 2014, is a prominent provider of Multi-Cloud Management Platform solutions in China. The company focuses on enhancing the cloud management experience for enterprise customers navigating multi-cloud environments, addressing challenges related to IT operation security and continuous application delivery. FIT2CLOUD offers a range of products, including its Cloud Management Platform, JumpServer (an open-source fortress machine), DataEase (an open-source data visualization and analysis platform), and MeterSphere (an open-source continuous testing platform). Through these offerings, FIT2CLOUD enables enterprises to effectively manage and control their cloud services, thereby facilitating digital transformation and improving operational efficiency.

Apexigen

Series C in 2020
Apexigen Inc. is a clinical-stage biopharmaceutical company based in San Carlos, California, dedicated to the discovery and development of antibody therapeutics for cancer treatment. The company focuses on creating innovative immuno-oncology products that leverage the patient's immune system to effectively combat and eliminate cancer. Apexigen's therapeutic pipeline includes several candidates such as APX005M and APX201 for immuno-oncology, alongside APX003 and TRK-950 for oncology, as well as APX001 for inflammation and APX003 for ocular diseases. Additionally, the company has developed the APXiMAB platform, which facilitates the discovery of antibodies targeting novel immune system components. Founded in 2010, Apexigen aims to advance next-generation therapies that address significant unmet needs in cancer treatment.

Amunix

Series A in 2020
Amunix Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to discovering and developing innovative protein and peptide therapeutics aimed at treating cancer. The company employs several proprietary platforms, including XTEN for extending drug half-life, XPAT for analyzing protease activity in the tumor microenvironment, and ProTIA, which focuses on immuno-oncology therapeutics. Amunix's product pipeline includes prodrugs and transformative T-cell engagers designed to activate the immune system against solid tumors. The company collaborates with various academic, biotechnology, and pharmaceutical sectors, maintaining strategic partnerships with organizations such as Janssen and Biogen-Idec. Founded in 2006 and headquartered in Mountain View, California, Amunix strives to deliver breakthroughs that can harness the immune system to combat cancer more effectively.

Barrot

Seed Round in 2020
Barrot is a developer and manufacturer of wireless Bluetooth technologies, focusing on the production of Bluetooth chips and modules. The company specializes in applications for various sectors, including automobiles, intelligent homes, wireless audio, wireless printing, and intelligent manufacturing. By providing essential wireless technology, Barrot supports companies and manufacturers in integrating advanced connectivity solutions into their products.

Hummingbird Bioscience

Series B in 2019
Hummingbird Bioscience focuses on the development of innovative therapeutic antibody-based drugs aimed at addressing significant unmet needs in oncology and immuno-oncology. Utilizing a proprietary rational antibody discovery platform, the company leverages systems biology and computational methods to gain insights into disease mechanisms, guiding the discovery and engineering of new biotherapeutics. Hummingbird's pipeline includes promising drug candidates such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both targeting cancer treatment. The company has formed strategic collaborations with organizations like Cancer Research UK and Amgen and has received a product development grant from the Cancer Prevention and Research Institute of Texas. This collaborative approach enhances Hummingbird's capacity to deliver effective therapies for patients with challenging medical conditions.

SeekGene

Seed Round in 2019
SeekGene specializes in genetic data analysis solutions, particularly in the development and clinical application of single-cell sorting assays. The company leverages its extensive research and clinical service experience to advance single-cell sequencing technology for real-world clinical research. SeekGene has developed a high-throughput single-cell transcriptome sequencing kit that is recognized for its superior performance, flexibility, and cost-effectiveness. This technology aims to facilitate the clinical transformation of single-cell sequencing, enabling better understanding of immune responses at the single-cell level. Additionally, SeekGene focuses on T cell receptor and peptide-bound major histocompatibility complex pairing technologies, which are essential for clinical and drug research, as well as for monitoring and treating various diseases.

HiFiBiO

Series C in 2019
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.

Lemon Photonics

Series A in 2019
LEMON Photonics Technologies Co. Ltd. is a high-tech company based in Shenzhen, China, established in 2018 by a team of experienced professionals in the laser industry. The company specializes in the research, development, sale, and industrialization of semiconductor electro-optical devices, modules, and systems. LEMON offers a range of products, including low-power direct diode lasers, fiber-coupled diode lasers, and high-power direct diode lasers, catering to various industrial applications.

Rinfon

Series B in 2019
Rinfon specializes in the research, development, production, sales, and service of communication products for satellites and unmanned aerial vehicles (UAVs). As a leading provider in this sector, the company focuses on delivering satellite signal modules, systems, and comprehensive solutions tailored for satellite and drone applications. Rinfon's offerings include advanced wireless communication systems and testing solutions aimed at enhancing the performance and reliability of unmanned platforms. Through its innovative products, Rinfon aims to meet the growing demand for effective communication technologies in the aerospace industry.

KnowBox

Series D in 2019
KnowBox, established in 2014, is focused on the K12 education sector, providing two mobile apps designed to enhance homework management for both students and teachers. The apps deliver personalized exercises that cater to individual learning needs, helping students maximize their homework effectiveness. For teachers, the platform alleviates repetitive tasks, allowing them to dedicate more time to address each student's specific challenges. With nearly one million daily active users, KnowBox is committed to further developing its services, including plans to create its own comprehensive homework database to better support educational outcomes.

Guofu Hydrogen

Series A in 2019
Furui Hydrogen was started by Furui Special Equipment Co. Ltd, a listed public company (stock 300338.sz) in China with market value of 3.8 billion RMB. Furui Special Equipment is a leader in LNG equipment market, and is credited with building up the LNG-transportation market in China. Furui Hydrogen aims to build up the hydrogen-for-mobility industry in China. Furui Hydrogen is a leader in the infrastructure equipment sector focused on heavy equipment for hydrogen fueling stations, on-vehicle hydrogen tanks and hydrogen liquefaction equipment. Furui Hydrogen targets three markets: Hydrogen filling station equipment, FCV hydrogen supply system and H2 liquifying system.

Panorama Medicine

Seed Round in 2019
Panorama Medicine, Inc. is a biotechnology company founded in 2018 and located in Bala Cynwyd, Pennsylvania. The company specializes in developing a drug discovery platform that combines genomics, big data, and artificial intelligence to identify and address RNA defects associated with various diseases. By integrating advanced data analysis and drug screening, Panorama Medicine aims to create therapeutic interventions that can effectively target genetically-defined conditions through RNA splicing modulation. This innovative approach positions the company to support medical organizations in enhancing their disease detection and treatment capabilities.

Archiwave Micro

Series A in 2019
Anqiwei Microelectronics was incorporated in July 2015 to focus on the development of high-performance RF microwave integrated circuits and module products based on silicon germanium SiGe BiCMOS, silicon-on-insulator SOI-CMOS and bulk silicon CMOS processes. Dr. Lu Jianhua, the founder of the company, received his Ph.D. from the University of California, Los Angeles (UCLA) and has been involved in RF and microwave integrated circuit design and product development in California. His products have won the ECN Impact Award. And Microwave Journal Best Product, and published the IEEE JSSC paper and several US patents as the first author. Several other core co-founders are top RF RF chip and system experts in the country and have accumulated decades of industry experience.

Recida Therapeutics

Series A in 2019
Recida Therapeutics is a biotechnology company focused on developing innovative antibiotic drugs to combat serious infections caused by antibiotic-resistant bacteria. The company's primary aim is to create novel-class antibiotics that specifically target multi-drug resistant gram-negative bacteria, which pose significant health risks to patients. By addressing the growing challenge of antibiotic resistance, Recida Therapeutics seeks to provide effective therapeutic options for individuals facing potentially life-threatening infections.

Dfocus

Series A in 2018
DFocus operates as a leading technology company specializing in cloud-based software for workspace planning and management. Founded in 2015 and headquartered in Shanghai, China, DFocus leverages Internet of Things (IoT) technology to provide innovative services to the real estate industry. The company serves over 200 large enterprises globally, including nearly 100 Fortune Global 500 companies such as Microsoft, Huawei, and Alibaba. Through the use of high-precision sensors, SaaS, and big data analysis, DFocus helps organizations improve space utilization and reduce operational costs. Additionally, it offers a real estate asset management platform that optimizes investment portfolios and enhances overall management efficiency. DFocus collaborates with prominent institutions and enterprises, including Tongji University and BOMA, to advance industry standards and practices.

Majorsec

Series A in 2018
Majorsec specializes in enterprise-level endpoint security, focusing on operating system-based threat detection and protection. The company provides advanced security technologies such as endpoint detection and response (EDR), cloud workload protection platforms (CWPP), and adaptive micro-segmentation. These solutions are designed to bolster users' defenses against various cyber threats, including ransomware, advanced persistent threats (APTs), and anti-kill Trojan horses. Additionally, Majorsec enhances organizations' capacity to monitor and manage the internal security status of hosts across their entire network, ensuring a robust security posture against evolving threats.

BooCax

Series A in 2018
Beijing BooCax Technology Co., Ltd. specializes in core positioning and navigation technology for industrial mobile robots. The company provides a robotic flexible collaboration system platform and automated guided vehicle (AGV) products. In addition to its focus on industrial applications, BooCax is involved in developing technologies that enhance indoor air management through intelligent mobile robots, aimed at disinfection and air quality improvement.

DBSec

Series C in 2018
DBSec is a reputable supplier of data security products, services, and solutions. They provide database encryption systems, database audit systems, cloud data security products, and holistic data security solutions. They serve the government, finance, social security, energy, military, operator, education, medical, and other industries.

ABAX Sensing

Venture Round in 2018
ABAX is developing an ultra-low cost, small form factor automotive grade Lidar solution based on Frequency-Modulated Continuous Waves. The company is headquartered in Xian (CN).

OnKure Therapeutics

Series A in 2018
OnKure Therapeutics is a clinical-stage biotechnology company dedicated to the discovery and development of innovative cancer therapies. The company specializes in creating less toxic kinase inhibitor drugs and epigenetic therapies, including selective inhibitors of histone deacetylases. Its lead candidate, OKI-179, has demonstrated significant efficacy in preclinical models of hematological and solid tumor cancers, effectively reducing tumor growth both alone and in combination with other targeted therapies. Additionally, OnKure is advancing its HDAC3 selective inhibitor, OKI-422, into preclinical toxicology studies. The company's drug candidates are designed to directly target malignant cells, enhance the effects of small molecule therapies, and optimize the tumor microenvironment for improved checkpoint inhibition, addressing unmet medical needs in cancer treatment.

EcoFlow

Series A in 2018
EcoFlow is a mobile power company focused on transforming energy access through innovative mobile energy storage technology. The company designs and manufactures portable power stations, including battery-powered generators, aimed at providing eco-friendly and affordable energy solutions. EcoFlow's mission is to improve living standards and foster economic growth in regions where power shortages are prevalent. By leveraging advanced technologies, the company seeks to enhance inclusion and empower users with reliable portable power for both personal and professional applications.

Reo Tech

Seed Round in 2018
Reo Tech is a manufacturing company focused on developing electromagnetic technologies primarily for military applications. The firm specializes in creating signal equipment for various communication needs and offers products such as signal playback devices, drone jamming systems, radar signal simulation tools, and transceiver modules. By leveraging advanced technology, Reo Tech enables users to effectively conduct signal operations and enhance electronic countermeasures in complex electromagnetic environments.

Chance Pharmaceuticals

Series A in 2018
Chance Pharmaceuticals is engaged in the discovery, development, and commercialization of inhalation therapies aimed at treating serious diseases, including chronic obstructive pulmonary disease, asthma, pulmonary arterial hypertension, and central nervous system disorders. The company specializes in the development of generic drugs that utilize dry powder inhalation delivery systems. This innovative approach allows for cost-effective manufacturing by improving the technology behind powder aerosols, making it more accessible for researchers and ultimately benefiting patients with debilitating respiratory conditions.

MicuRx Pharmaceuticals

Series D in 2017
MicuRx Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering and developing antibiotics to address drug-resistant bacterial infections. Founded in 2007 and headquartered in Palo Alto, California, the company has established a hybrid business model that leverages U.S. research and development alongside cost-effective scientific resources in China. MicuRx's product lineup includes MRX-I, an oral antibiotic targeting multi-drug resistant gram-positive pathogens, and its intravenous prodrug form, MRX-IV. Additionally, the company offers MRX-V, an injectable antibiotic for gram-negative bacteria, and MRX-VIII, a polymyxin for gram-negative infections. The company is also working on a pipeline of antibacterial drugs aimed at combating both gram-positive and gram-negative bacterial pathogens. MicuRx's subsidiary, Shanghai MicuRx, is responsible for commercializing its agents in China while global clinical studies continue.

12 Sigma Technologies

Series B in 2017
12 Sigma Technologies, founded in April 2015, specializes in modern medical image diagnosis and medical data analysis, leveraging advanced artificial intelligence technology. The company focuses on the integration of medical imaging and AI, recognizing the substantial potential in this combination for enhancing diagnostic capabilities. To advance its offerings, 12 Sigma has established partnerships with General Electric to co-develop smart diagnostic products aimed at addressing conditions such as tumors and cardiovascular diseases. Additionally, the company collaborates with over 50 leading hospitals in China to conduct applied medical diagnostics, technical research, and clinical trials, positioning itself as a key player in the healthcare technology sector.

UniZ

Series A in 2017
UniZ is a technology startup based in San Diego, California, founded in February 2014 by a group of engineers. The company specializes in the development and distribution of high-performance 3D printing solutions, particularly for dental professionals and laboratories. UniZ's product offerings include advanced 3D printers, post-processing devices, and specialized printing materials designed to enhance operational efficiency for its clients. By focusing on affordability and quality, UniZ aims to make 3D printing accessible and practical for a wide range of applications, helping to turn innovative concepts into tangible products.

Chance Pharmaceuticals

Angel Round in 2016
Chance Pharmaceuticals is engaged in the discovery, development, and commercialization of inhalation therapies aimed at treating serious diseases, including chronic obstructive pulmonary disease, asthma, pulmonary arterial hypertension, and central nervous system disorders. The company specializes in the development of generic drugs that utilize dry powder inhalation delivery systems. This innovative approach allows for cost-effective manufacturing by improving the technology behind powder aerosols, making it more accessible for researchers and ultimately benefiting patients with debilitating respiratory conditions.

Zhongqu Technology

Angel Round in 2016
Zhongqu (Beijing) Technology Co., Ltd. is a company that specializes in the development of 3D scanning camera technology. Founded in 2014, it is located in Beijing, China. The company focuses on creating innovative solutions in the field of 3D scanning, catering to various applications and industries.

Weizhi Keji

Series A in 2015
Weizhi Keji is a market information consultation and investigation industry.

51 Dinghuo

Series A in 2015
Fengyun Network offers industrial internet services in the communications, pan-maternal, and infant industries, providing integrated services of commodity supply chain, scenario financial solutions, and digital technology to the upstream and downstream customers of the industry.

Chinaly New Materials

Venture Round in 2015
Chinaly New Materials focuses on the development, production, and marketing of lithium-ion battery separators.

HJIMI

Angel Round in 2015
HJIMI is a high-tech company that specializes in artificial intelligence with a focus on 3D computer vision, intelligent human-machine interaction, and 3D AR and MR technology. They serve retail, smart homes, consumer electronics, logistics, and other fields.

Nengdong Yingyu

Angel Round in 2014
Nengdong Yingyu is a learning and education platform. Active English has created a comprehensive set of scientific and rigorous curriculum systems to assist thousands of youngsters in learning English effortlessly and cheerfully. They provide services that include digital learning methods and products that include phonetic code, sentence rubik's cubes, and nine-nine syntax.

zhz tech

Venture Round in 2014
ZHZ is an industrial company focused on the development of aerial vehicles, including drones and helicopters, tailored for the drone industry. The company provides a diverse range of products designed for short-term flight, operated via remote control. ZHZ's offerings cater to engineers and drone enthusiasts, with applications that span structure inspection, defense, and surveillance.

Nanjng Yueboo Power System

Seed Round in 2014
Nanjing Yueboo Power System develops, manufactures, and sells automotive power systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.